Literature DB >> 2115981

Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation.

C V Harding1, E R Unanue.   

Abstract

The number of specific complexes formed between peptide and the class II major histocompatibility complex (MHC) molecules expressed by an antigen-presenting cell (APC) after exposure to protein antigens is unknown, as is the number that activates T cells. Presentation of foreign peptides by APC takes place when many class II molecules may be occupied by autologous peptides. We have now estimated the number of specific peptide/class II complexes per APC by quantitative immunoprecipitation of I-Ak after pulsing the APC with stimulatory levels of a radioactive immunogenic peptide derived from hen egg-white lysozyme protein. T cells were activated by APC that expressed as few as 210-340 specific peptide/class II complexes (0.1% of the I-Ak molecules). These figures were confirmed using anti-CD3 antibody bound to latex beads as an alternative activating ligand. This low number explains the simultaneous presentation of multiple foreign antigens, even in the face of peptide competition.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115981     DOI: 10.1038/346574a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  132 in total

Review 1.  Imaging T-cell antigen recognition and comparing immunological and neuronal synapses.

Authors:  E Donnadieu; P Revy; A Trautmann
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

2.  A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.

Authors:  L Coscoy; D Ganem
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

3.  Inhibition of tyrosine kinases blocks adhesion-induced T-cell coactivation without interfering with T-cell adhesion to endothelial cell-surface ligands.

Authors:  Dawn M Nowlin; Pina M Cardarelli; Lynn Young; Jason Mah; Katherine A Felts; Marian Mastrangelo; Ronald R Cobb
Journal:  Inflammation       Date:  2002-02       Impact factor: 4.092

4.  Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation.

Authors:  Lisa K McNeil; Brian D Evavold
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

5.  Cooperative enhancement of specificity in a lattice of T cell receptors.

Authors:  C Chan; A J George; J Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

6.  Quantifying signaling-induced reorientation of T cell receptors during immunological synapse formation.

Authors:  William C Moss; Darrell J Irvine; Mark M Davis; Matthew F Krummel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-01       Impact factor: 11.205

7.  T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node.

Authors:  Mark J Miller; Arsalan S Hejazi; Sindy H Wei; Michael D Cahalan; Ian Parker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-13       Impact factor: 11.205

Review 8.  Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.

Authors:  Laurence C Eisenlohr; Nancy Luckashenak; Sebastien Apcher; Michael A Miller; Gomathinayagam Sinnathamby
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

9.  Distinct MHC class II molecules are associated on the dendritic cell surface in cholesterol-dependent membrane microdomains.

Authors:  Sanjay Khandelwal; Paul A Roche
Journal:  J Biol Chem       Date:  2010-09-10       Impact factor: 5.157

10.  Formation of supramolecular activation clusters on fresh ex vivo CD8+ T cells after engagement of the T cell antigen receptor and CD8 by antigen-presenting cells.

Authors:  T A Potter; K Grebe; B Freiberg; A Kupfer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.